Category : Medical conditions

Home / Archive by category "Medical conditions"

Jun 19, 2018

0

GROUP B STREP (GBS) IN LABOUR

Group B Strep GBS is the most common cause of severe infection in newborn babies and of meningitis in babies under 3 months old. Most early onset GBS infections (in babies aged 0?-?6 days) can be prevented by giving intravenous ..

Jun 15, 2018

0

NICE RECOMMENDATION FOR MODERATE TO SEVERE PLAQUE PSORIASIS

Guselkumab is recommended as an option for treating plaque psoriasis in adults, only if: the disease is severe, as defined by a total Psoriasis Area and Severity Index (PASI) of 10 or more and a Dermatology Life Quality Index (DLQI) of ..

Jun 12, 2018

0

ATRIAL FIBRILLATION

Recent figures show that there is an average of 25% of patients with a confirmed atrial fibrillation AF diagnosis are not on any anticoagulation medication. Some practices are as low as 50%. This could be potentially dangerous for this group of patients. ..

Jun 12, 2018

0

DIABETIC EYE SCREENING

Diabetic eye screening is important as it helps to prevent sight loss. As someone with diabetes, your eyes are at risk of damage from diabetic retinopathy. Screening can detect the condition early before you notice any changes to your vision.

Jun 12, 2018

0

DIABETES AWARENESS RISK ASSESSMENT TOOL

A non-invasive risk assessment tool, Know Your Risk, can be used in the community to identify those at risk of diabetes and encourage blood testing for those at high or moderate risk. A letter is generated online that can be taken in to ..

Jun 12, 2018

0

SEPSIS

NICE guidance on sepsis (July 2016) highlights the challenges of spotting sepsis: signs and symptoms can be very non- specific, so a high index of suspicion is needed. If clinicians do not ask themselves ‘Could this be sepsis?’ the opportunity ..

Jun 5, 2018

0

HEPATIC ENCEPHALOPATHY & CIRRHOSIS

The NICE guideline NG50 National Institute for Clinical excellence is about hepatic encephalopathy being a major complication of cirrhosis. Approximately 50% of people with cirrhosis will develop clinically apparent hepatic encephalopathyat some stage after diagnosis – the risk being around 5-25% ..

Jun 24, 2015

0

Dr Martin Harris addresses BMA conference on DoLS Deprivation of Liberty Safeguards

, ,

Dr Martin Harris GP and elected representative spoke at the BMA annual conference in Liverpool about Deprivation of Liberty Safeguards (DoLS). this was originally intended to benefit the patient, providing assessment and funding care. Unfortunately with a death is non suspicious such as dementia, ..